Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]
Genre
Journal articleDate
2022-06-14Author
Brooks, Benjamin RixHeiman-Patterson, Terry
Wiedau-Pazos, Martina
Liu, Shawn
Zhang, Jeffrey
Apple, Stephen
Department
NeurologySubject
Amyotrophic lateral sclerosisLinear regression analysis
Antioxidant therapy
Diagnostic medicine
Oxidative stress
Regression analysis
Death rates
Phase III clinical investigation
Permanent link to this record
http://hdl.handle.net/20.500.12613/9729